Wearables and digital health technologies are transforming how we capture real-world outcomes in clinical trials. However, moving to full-scale execution presents significant operational, logistical, and compliance hurdles.
Join Sysnav Healthcare and a panel experts from Biogen, Precision BioSciences and REGENXBIO as they share practical strategies for successfully deploying digital endpoints at scale.
- Date: Friday, September 18
- Time: 10:00 AM – 11:00 AM ET
- Format: Live Virtual Webinar + Interactive Q&A
Featured Speakers
- Catherine Wilson, Director, Clinical Outcomes Research, REGENXBIO
- Drew Scruggs, Associate Director of Clinical Operations & Patient Advocacy, Precision BioSciences
- Joshua Guo, Associate Director, Emerging Technologies Regulatory Affairs & Quality Assurance, Biogen
- Damien Eggenspieler, Program Director, Sysnav Healthcare
- Moderator: Yacine Bechichi, Head of Partnerships, Sysnav Healthcare
What We’ll Explore
- Debunking the biggest misconceptions sponsors face when moving from conventional trials to wearable-enabled studies.
- What it actually takes to make a trial protocol “wearable-ready” versus merely compatible.
- The essential scientific, regulatory, and operational evidence needed to prove a wearable technology is truly “trial-ready.”
- Practical considerations and key criteria to include on your wearable vendor checklist.
- Real-world anecdotes from international deployments, highlighting what drives success and what leads to failure.
- Navigating feedback, concerns, and opportunities from patient advocates and regulatory bodies.
Make sure to reserve your spot here!
